IQVIA Logo

Insight

Cross-Modality Validation of an iPSC-Derived Blood–Brain Barrier Model Using Small Molecules, Antibodies, and Antisense Oligonucleotides

Scientific poster presented at Society for Neuroscience (SfN) annual meeting 2026, in Washington, DC.
Cross-Modality Validation of an iPSC-Derived Blood–Brain Barrier Model Using Small Molecules, Antibodies, and Antisense Oligonucleotides
Home / Insights / Cross-Modality Validation of an iPSC-Derived Blood–Brain Barrier Model Using Small Molecules, Antibodies, and Antisense Oligonucleotides

This poster describes the evaluation of an in vitro human iPSC-derived blood-brain barrier (BBB) model to assess the BBB permeability of small molecules, therapeutic monoclonal antibodies, and antisense oligonucleotides.

 

Authors: Malika Bsibsi1, Lianne van Beek1, Cindy J.M. Loomans1, Ludovico Buti1, Timur Yavezturk1, Narendra Chunduri1, Fatma Masmoudi1, Rebecca Beaumont2 and Anne-Marie Zuurmond1. 
1: IQVIA Laboratories, Leiden, Netherlands
2: IQVIA Laboratories, Cambridge, UK

 


Download Document